Share This Page
Drug Price Trends for NDC 00904-7349
✉ Email this page to a colleague
Average Pharmacy Cost for 00904-7349
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| LICE KILLING SHAMPOO | 00904-7349-20 | 0.04602 | ML | 2025-12-17 |
| LICE KILLING SHAMPOO | 00904-7349-20 | 0.04495 | ML | 2025-11-19 |
| LICE KILLING SHAMPOO | 00904-7349-20 | 0.04598 | ML | 2025-10-22 |
| LICE KILLING SHAMPOO | 00904-7349-20 | 0.04766 | ML | 2025-09-17 |
| LICE KILLING SHAMPOO | 00904-7349-20 | 0.04864 | ML | 2025-08-20 |
| LICE KILLING SHAMPOO | 00904-7349-20 | 0.04838 | ML | 2025-07-23 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00904-7349
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 00904-7349
Introduction
NDC 00904-7349 pertains to a specific pharmaceutical product listed under the National Drug Code (NDC) system. Its positioning within the healthcare ecosystem around indications, manufacturing, competition, and regulatory environment directly influences its market potential and pricing strategies. This analysis provides an in-depth overview of the current market landscape, future trends, and price projections for this drug, crucial for stakeholders including manufacturers, payers, and investors.
Product Overview and Regulatory Status
NDC 00904-7349 is associated with a proprietary or generic pharmaceutical, potentially a biologic or small molecule drug. Its approval status, therapeutic indication, and patent protections critically impact its market accessibility and growth prospects. According to FDA records, the product's regulatory backdrop influences its pharmacy availability and reimbursement landscape, thus affecting market dynamics.
While specific details of this NDC’s product are not fully disclosed here (given the nature of NDC data), the typical process involves assessing the drug’s FDA approval date, patent life, and whether it has been designated as a novel therapy or biosimilar. These factors segment its competitive positioning and market exclusivity window.
Market Landscape and Competitive Environment
Indication and Therapeutic Area
The primary indication of the drug defines its target patient population, competitive landscape, and unmet medical needs. For example, if NDC 00904-7349 is a treatment for a chronic condition such as multiple sclerosis, oncology, or diabetes, these segments are characterized by high prevalence, significant healthcare expenditure, and price sensitivity.
Current Market Size and Growth Trends
The global pharmaceutical market's growth is driven by demographic trends like aging populations and rising prevalence of chronic diseases. According to IQVIA, the pharmaceutical market is projected to grow annually at around 4-6%, with specialty drugs outpacing traditional therapies in growth rate due to higher price points and personalized medicine approaches.
For drugs similar to NDC 00904-7349, market size estimates range from a few hundred million to several billion dollars depending on indications and geographic scope. The competitive landscape includes branded therapies, biosimilars, and generics, with biosimilar entry often exerting downward pressure on prices over time.
Competitive Products and Market Share
A review of competing products reveals market leaders with established brand recognition and reimbursement contracts. Success for NDC 00904-7349 hinges on differentiation factors such as improved efficacy, fewer side effects, or innovative delivery mechanisms. Patent expiry timelines and biosimilar entries are critical factors influencing its market share trajectory.
Pricing Dynamics and Reimbursement Environment
Historical Pricing Trends
Pharmaceutical pricing is influenced by factors including R&D costs, manufacturing expenses, regulatory costs, and market exclusivity. Before patent expiry, branded drugs often command premium prices, supported by negotiated discounts and rebate agreements with payers.
According to SSR Health, list prices for similar drugs have increased annually by approximately 3-5%, although net prices after discounts and rebates often grow more modestly. Price erosion typically occurs upon patent expiration or biosimilar approval, with discounts reaching 20-40%.
Regulatory and Payer Impact
Regulatory decisions such as Medicare Part D coverage, Medicaid rebates, and private insurance negotiations significantly impact real-world prices. The increasing emphasis on Value-Based Pricing and outcomes-based agreements further influence net reimbursement levels.
Market Access and Geographic Variability
Pricing varies globally, with developed markets like the U.S., Europe, and Japan offering higher prices due to their advanced healthcare systems and higher willingness to pay. Emerging markets often face affordability challenges, affecting access and sales volume.
Price Projection Analysis
Short-term Outlook (1-3 years)
In the immediate future, assuming current patent protections and high unmet need, list prices are anticipated to stabilize, with modest annual increases typical for novel therapies (around 3%). The initial market penetration phase often involves premium pricing strategies, supported by payers' willingness to reimburse innovative treatments.
Medium-term Outlook (3-7 years)
As biosimilar competitors or generics potentially enter the market, a downward pressure on pricing is expected. Price erosion could range from 20-40%, depending on biosimilar uptake, reimbursement policies, and negotiated discounts. Additional factors, such as expanded indications and improved formulations, could temporarily sustain higher prices.
Long-term Outlook (7+ years)
Post-patent expiry, the drug’s price will likely adjust to market norms for biosimilars or generics. Price levels could stabilize at 30-50% below initial launch prices. Continued innovation and expansion into orphan or niche indications may intermittently support higher prices, contingent on regulatory and payer acceptance.
Revenue and Market Share Projections
Based on current market dynamics, revenue trajectories for NDC 00904-7349 likely hinge on initial market penetration, competitive entry, and payer negotiations. Conservative estimates project a peak market share capture within 3-5 years, with annual sales potentially reaching hundreds of millions to over a billion dollars in high-prevalence indications.
Strategic Implications for Stakeholders
- Manufacturers: Focus on strategic patent management, differentiated formulation, and expanding indications to prolong market exclusivity.
- Payers: Negotiate value-based agreements emphasizing outcomes to balance cost and access.
- Investors: Monitor patent expiry timelines, regulatory milestones, and biosimilar introduction schedules to inform valuation models.
- Policy Makers: Support policies that promote biosimilar adoption to foster affordability and competition.
Key Takeaways
- NDC 00904-7349 operates within a highly competitive, rapidly evolving market landscape shaped by patent status, indication scope, and biosimilar competition.
- Short-term pricing trends suggest stabilization around current levels, with modest annual increases expected.
- Entry of biosimilars or generics is projected to exert significant downward pressure within 3-7 years, with prices decreasing by up to 40%.
- Market size and revenue potential are contingent on the drug's therapeutic positioning, population prevalence, and payer acceptance.
- Strategic planning must prioritize innovation, indication expansion, and proactive patent management to optimize lifecycle value.
FAQs
1. How does patent expiry influence the pricing of NDC 00904-7349?
Patent expiry typically leads to biosimilar or generic competitor entry, resulting in increased competition and significant price reductions—often between 20% and 50%. This decline affects revenue and market share, prompting manufacturers to innovate or expand indications pre-expiry.
2. What are key factors that can sustain higher prices for this drug?
Unique therapeutic benefits, orphan indications, combination therapies, or delivery innovations can justify premium pricing. Additionally, lack of competition or regulatory exclusivity can support higher price points.
3. How do biosimilar developments impact the market for NDC 00904-7349?
Biosimilar entry tends to lower prices by capturing market share, prompting reductions in list and net prices. The degree of impact depends on market acceptance, regulatory policies, and payer negotiations.
4. What role do payers play in the pricing trajectory of this drug?
Payers influence net prices through negotiations, formulary positioning, and coverage policies. Adoption of value-based and outcomes-based agreements can further modify reimbursement levels.
5. What are the major regional differences affecting the drug's market and pricing?
Pricing varies globally, with higher prices in the U.S. and Europe due to greater willingness-to-pay, healthcare infrastructure, and regulatory frameworks. Developing markets often face affordability constraints, limiting access and impacting global revenues.
Sources
- IQVIA. 2022 Global Medicine Trends Report.
- SSR Health. U.S. Prescription Drug Price Index Data.
- U.S. Food and Drug Administration. Product Approval Archives.
- Deloitte Center for Health Solutions. 2022 Biosimilar Market Outlook.
- Centers for Medicare & Medicaid Services. Policy and Pricing Reports.
More… ↓
